BCMA Therapy Sequencing in Myeloma: Real-world data and expert discussion show CAR-T and BCMA bispecifics are often chosen based on patient fitness, prior treatment history, access, and logistics—rather than head-to-head efficacy—highlighting the need for better prospective guidance in relapsed/refractory multiple myeloma. Cancer Disparities: A JAMA Network Open study links socially vulnerable neighborhoods to worse ovarian cancer survival, with a sharper impact for Black women. Hepatitis C Elimination Push: WHO reiterates its 2030 hepatitis elimination targets, while progress depends on diagnosing and moving people into treatment; rapid-clearance regimens like glecaprevir/pibrentasvir support faster care pathways. Drug Supply & Tariffs Risk: Analysts warn Trump’s proposed drug tariffs could disrupt India’s “pharmacy of the world” model, threatening low-cost generics that drive most US prescriptions. Public Health & Safety: UK data shows e-scooter injuries involving children have surged, with few riders wearing helmets; meanwhile, pool safety guidance stresses constant supervision to prevent drownings. Healthcare Costs in India: Private hospitals and NATHEALTH oppose a proposed cap on room charges tied to nearby hotel rates, arguing clinical complexity and staffing drive costs. Biotech & Innovation: CN Bio wins an Innovate UK grant to cut animal use in pharmacokinetic studies using organ-on-a-chip plus modeling; Pharvaris reports progress toward deucrictibant angioedema milestones. Mental Health Policy: India flags postpartum depression as a national policy and screening gap, with calls for structured support for new mothers.